BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25045154)

  • 1. Acute liver allograft antibody-mediated rejection: an inter-institutional study of significant histopathological features.
    O'Leary JG; Michelle Shiller S; Bellamy C; Nalesnik MA; Kaneku H; Jennings LW; Isse K; Terasaki PI; Klintmalm GB; Demetris AJ
    Liver Transpl; 2014 Oct; 20(10):1244-55. PubMed ID: 25045154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss.
    O'Leary JG; Kaneku H; Demetris AJ; Marr JD; Shiller SM; Susskind BM; Tillery GW; Terasaki PI; Klintmalm GB
    Liver Transpl; 2014 Feb; 20(2):218-27. PubMed ID: 24382837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obliterative portal venopathy: A histopathologic finding associated with chronic antibody-mediated rejection in pediatric liver allografts.
    Guerra MR; Naini BV; Scapa JV; Reed EF; Busuttil RW; Cheng EY; Farmer DG; Vargas JH; Venick RS; McDiarmid SV; Wozniak LJ
    Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29363222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
    Ali S; Ormsby A; Shah V; Segovia MC; Kantz KL; Skorupski S; Eisenbrey AB; Mahan M; Huang MA
    Transpl Immunol; 2012 Jan; 26(1):62-9. PubMed ID: 21907804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
    Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
    Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and treatment of liver allograft antibody-mediated rejection and the role of the 'two-hit hypothesis'.
    Kim PT; Demetris AJ; O'Leary JG
    Curr Opin Organ Transplant; 2016 Apr; 21(2):209-18. PubMed ID: 26918881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic and immunophenotypic evaluation of liver allograft biopsies with contemporaneous serum DSA measurements.
    El Hag MI; Kaneku H; Jorgensen D; Zeevi A; Stevenson HL; Yadak N; Hassan M; Du X; Demetris AJ
    Clin Transplant; 2023 Aug; 37(8):e14997. PubMed ID: 37096730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-mediated rejection of renal allograft in combined liver-kidney transplant.
    Barth RN; Campos L; Kukuruga DL; Drachenberg C; Philosophe B
    Clin Transplant; 2010; 24(5):685-90. PubMed ID: 19925465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-mediated rejection in pediatric liver transplant recipients.
    Markiewicz-Kijewska M; Kaliciński P; Kluge P; Piątosa B; Rękawek A; Jankowska I; Kostecka E; Kurowski PN
    Ann Transplant; 2014 Mar; 19():119-23. PubMed ID: 24594760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased macrophage density of cardiac allograft biopsies is associated with antibody-mediated rejection and alloantibodies to HLA antigens.
    Xu L; Collins J; Drachenberg C; Kukuruga D; Burke A
    Clin Transplant; 2014 May; 28(5):554-60. PubMed ID: 24580037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma C4d+ Endothelial Microvesicles Increase in Acute Antibody-Mediated Rejection.
    Tower CM; Reyes M; Nelson K; Leca N; Kieran N; Muczynski K; Jefferson JA; Blosser C; Kukla A; Maurer D; Chandler W; Najafian B
    Transplantation; 2017 Sep; 101(9):2235-2243. PubMed ID: 27846156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pathological analyses of transplant glomerulopathy cases.
    Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
    Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic Characteristics of Late Acute Antibody-mediated Rejection in Pediatric Liver Transplantation.
    Zhou S; Mitsinikos T; Emamaullee J; Weaver C; Wang L; Shillingford N; Warren M; Bawab JH; Tiwari N; Genyk Y; Thomas D; Parham DM
    Transplantation; 2021 Sep; 105(9):2045-2053. PubMed ID: 33031223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
    Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
    Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
    Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation.
    Cuadrado A; San Segundo D; López-Hoyos M; Crespo J; Fábrega E
    World J Gastroenterol; 2015 Oct; 21(39):11016-26. PubMed ID: 26494958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinctive morphological features of antibody-mediated and T-cell-mediated acute rejection in pancreas allograft biopsies.
    Papadimitriou JC; Drachenberg CB
    Curr Opin Organ Transplant; 2012 Feb; 17(1):93-9. PubMed ID: 22227719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-Mediated Rejection After Liver Transplant.
    Lee M
    Gastroenterol Clin North Am; 2017 Jun; 46(2):297-309. PubMed ID: 28506366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of complement component 4d immunohistochemistry to ABO-compatible and ABO-incompatible liver transplantation.
    Salah A; Fujimoto M; Yoshizawa A; Yurugi K; Miyagawa-Hayashino A; Sumiyoshi S; Minamiguchi S; Uemoto S; Maekawa T; Haga H
    Liver Transpl; 2014 Feb; 20(2):200-9. PubMed ID: 24470446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.